Basics Zevra Therapeutics, Inc. IPO Date: April 13, 2015 Sector: Healthcare Industry: Biotech Market Cap: $623.1M Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 2.53% Avg Daily Range (30 D): $0.30 | 3.22% Avg Daily Range (90 D): $0.26 | 2.59% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): 2.16M Avg Daily Volume (90 D): 1.51M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 107 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 188 Avg Inst. Trade: $1.26M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.51M Avg Closing Trade (30 D): $1.24M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 179.79K     News Oct 6, 2025 @ 9:51 PM Zevra Therapeutics Announces Inducement Grants und... Source: Nichol Ochsner Feb 27, 2025 @ 12:30 PM Zevra Therapeutics Enters Agreement to Sell its Ra... Source: Globe Newswire Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A Nov 21, 2024 @ 9:51 PM Zevra Therapeutics Announces U.S. Commercial Avail... Source: N/A Nov 11, 2024 @ 9:36 PM Zevra Therapeutics to Present Data Demonstrating R... Source: Zevra Therapeutics, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.18 $1.24 $-.06 Diluted EPS $1.21 $-.05 Revenue $ 62.02M $ 25.88M $ 20.4M Gross Profit $ $ $ Net Income / Loss $ 2.64M $ 74.71M $ -3.1M Operating Income / Loss $ -119.12M $ -71.04M $ -5.36M Cost of Revenue $ $ $ Net Cash Flow $ 7.99M $ 9.71M $ 3.93M PE Ratio     Splits Dec 28, 2020:   1:16